Intellikine, Inc. Secures $51,000,000 New Funding

  • Feed Type
  • Date
  • Company Name
    Intellikine, Inc.
  • Mailing Address
    10931 N. Torrey Pines Rd. La Jolla, CA 92037
  • Company Description
    Intellikine is a leader in the discovery and development of novel, small molecule therapies targeting the PI3K/Akt/mTOR pathway.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Biogen Idec Inc.
  • Venture Investor
    U.S. Venture Partners
  • Venture Investor
    FinTech Global Inc
  • Venture Investor
    Novartis Venture Fund

Trending on Xconomy